The tumor genotyping of five other patients showed a wild‐type EGFR gene, and these negative results could be linked to a low amount of tumor DNA, pre‐ or post‐analytic error, or spatial heterogeneity of the tumor. This evidence concerns the gene EGFR and neoplasm.